Activation of the reward system boosts innate and adaptive immunity

Nature Medicine

Volumn 22, Issue 8, 2016, Pages 940-944

  Ben Shaanan, Tamar L ^a   Azulay Debby, Hilla ^a   Dubovik, Tania ^a   Starosvetsky, Elina ^a   Korin, Ben ^a   Schiller, Maya ^a   Green, Nathaniel L ^a   Admon, Yasmin ^a   Hakim, Fahed ^a,b   Shen Orr, Shai S ^a   Rolls, Asya ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Pulmonary Unit   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; BACTERIUM ANTIBODY; CYTOKINE;

ADAPTIVE IMMUNITY; ADRENERGIC SYSTEM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL LOAD; DELAYED HYPERSENSITIVITY; DOPAMINERGIC NERVE CELL; ESCHERICHIA COLI; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; TIME OF FLIGHT MASS SPECTROMETRY; VENTRAL TEGMENTUM; ANIMAL; BACTERIUM; CHEMICAL SYMPATHECTOMY; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MOUSE; PHAGOCYTOSIS; PLACEBO EFFECT; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIA; CYTOKINES; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; ESCHERICHIA COLI; FLOW CYTOMETRY; HYPERSENSITIVITY, DELAYED; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MONOCYTES; PHAGOCYTOSIS; PLACEBO EFFECT; REWARD; SYMPATHECTOMY, CHEMICAL; SYMPATHETIC NERVOUS SYSTEM; T-LYMPHOCYTES; VENTRAL TEGMENTAL AREA;

EID: 84976872227     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4133     Document Type: Article

References (38)

1. Howick, J. et al. Placebo use in the United Kingdom: results from a national survey of primary care practitioners. PLoS One 8, e58247 (2013).
2. Tilburt, J.C., Emanuel, E.J., Kaptchuk, T.J., Curlin, F.A. & Miller, F.G. Prescribing 'placebo treatments': results of national survey of US internists and rheumatologists. BMJ 337, a1938 (2008).
3. de la Fuente-Fernández, R. et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164-1166 (2001).
4. Scott, D.J. et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 220-231 (2008).
5. Benedetti, F., Carlino, E. & Pollo, A. How placebos change the patient's brain. Neuropsychopharmacology 36, 339-354 (2011).
6. Walach, H. Placebo controls: historical, methodological and general aspects. Phil. Trans. R. Soc. Lond. B 366, 1870-1878 (2011).
7. D'Acquisto, F., Rattazzi, L. & Piras, G. Smile-it's in your blood! Biochem. Pharmacol. 91, 287-292 (2014).
8. Segerstrom, S.C. & Miller, G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130, 601-630 (2004).
9. Barak, Y. The immune system and happiness. Autoimmun. Rev. 5, 523-527 (2006).
10. Eisenberger, N.I. & Cole, S.W. Social neuroscience and health: neurophysiological mechanisms linking social ties with physical health. Nat. Neurosci. 15, 669-674 (2012).
11. Fredrickson, B.L. et al. A functional genomic perspective on human well-being. Proc. Natl. Acad. Sci. USA 110, 13684-13689 (2013).
12. Mittwoch-Jaffe, T., Shalit, F., Srendi, B. & Yehuda, S. Modification of cytokine secretion following mild emotional stimuli. Neuroreport 6, 789-792 (1995).
13. Segerstrom, S.C. & Sephton, S.E. Optimistic expectancies and cell-mediated immunity: the role of positive affect. Psychol. Sci. 21, 448-455 (2010).
14. Segerstrom, S.C., Taylor, S.E., Kemeny, M.E. & Fahey, J.L. Optimism is associated with mood, coping and immune change in response to stress. J. Pers. Soc. Psychol. 74, 1646-1655 (1998).
15. Nieh, E.H., Kim, S.Y., Namburi, P. & Tye, K.M. Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors. Brain Res. 1511, 73-92 (2013).
16. Russo, S.J. & Nestler, E.J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 14, 609-625 (2013).
17. Schultz, W. Updating dopamine reward signals. Curr. Opin. Neurobiol. 23, 229-238 (2013).
18. Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S. & Roth, B.L. Evolving the lock to fit the key to create a family of G-protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163-5168 (2007).
19. Huston, J.P., Silva, M.A., Topic, B. & Müller, C.P. What's conditioned in conditioned place preference? Trends Pharmacol. Sci. 34, 162-166 (2013).
20. Gunaydin, L.A. et al. Natural neural projection dynamics underlying social behavior. Cell 157, 1535-1551 (2014).
21. Bendall, S.C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687-696 (2011).
22. Gratton, A., Hoffer, B.J. & Gerhardt, G.A. Effects of electrical stimulation of brain reward sites on release of dopamine in rat: an in vivo electrochemical study. Brain Res. Bull. 21, 319-324 (1988).
23. Connolly, B.S. & Lang, A.E. Pharmacological treatment of Parkinson disease: a review. J. Am. Med. Assoc. 311, 1670-1683 (2014).
24. Elenkov, I.J., Wilder, R.L., Chrousos, G.P. & Vizi, E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638 (2000).
25. Koopman, F.A. et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol. Med. 17, 937-948 (2011).
26. Nakamoto, T. et al. Co-activation of renal sympathetic neurons and somatic motor neurons by chemical stimulation of the midbrain ventral tegmental area. J. Appl. Physiol. 110, 1342-1353 (2011).
27. Kostrzewa, R.M. & Jacobowitz, D.M. Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26, 199-288 (1974).
28. Lacosta, S., Merali, Z., Zalcman, S. & Anisman, H. Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge. Brain Res. 664, 225-230 (1994).
29. Saurer, T.B., Ijames, S.G. & Lysle, D.T. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. J. Pharmacol. Exp. Ther. 329, 1040-1047 (2009).
30. Balfour, M.E., Yu, L. & Coolen, L.M. Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 29, 718-730 (2004).
31. Hajnal, A., Smith, G.P. & Norgren, R. Oral sucrose stimulation increases accumbens dopamine in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R31-R37 (2004).
32. Enck, P., Benedetti, F. & Schedlowski, M. New insights into the placebo and nocebo responses. Neuron 59, 195-206 (2008).
33. National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, 2011).
34. Lammel, S. et al. Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron 85, 429-438 (2015).
35. Rogan, S.C. & Roth, B.L. Remote control of neuronal signaling. Pharmacol. Rev. 63, 291-315 (2011).
36. Bruggner, R.V., Bodenmiller, B., Dill, D.L., Tibshirani, R.J. & Nolan, G.P. Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl. Acad. Sci. USA 111, E2770-E2777 (2014).
37. Parmigiani, G., Garrett, E.S., Anbazhagan, R. & Gabrielson, E. A statistical framework for expression-based molecular classification in cancer. J. R. Stat. Soc. Series B Stat. Methodol. 64, 717-736 (2002).
38. Heller, E.D., Leitner, H., Drabkin, N. & Melamed, D. Passive immunization of chicks against Escherichia coli. Avian Pathol. 19, 345-354 (1990).